- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01204424
Clinical Investigation to Assess the Safety and Feasibility of the Crestal, Minimal-invasive Sinus Floor Augmentation With the Pressure Chamber Drill (DKK) and the Sinus Vibration Pump (SVP) (DKK SVP)
Klinische Prüfung Zur Untersuchung Der Sicherheit Und Machbarkeit Des Crestalen, Minimal-invasiven Kieferknochenaufbaus (Sinuslift) Mit Der Druck-kammerknochenfräse (DDK) Und Der Sinusvibrationspumpe (SVP)
The success of dental implants is based on a variety of factors including; surgical technique, health of the patient, operator skill and, to a significant part, sufficient bone for the placement and integration of dental implants. To that end, the replacement of the maxillary posterior teeth have presented a considerable challenge because, after the loss of maxillary posterior teeth the quality and quantity of the remaining supporting bone may be insufficient to support implants properly or reliably. To overcome the deficiency of insufficient vertical bone mass of the maxilla, several surgical techniques have been developed to increase available bone mass for the replacement of dental implants by bone augmentation.
The conventional procedure for a sinus lift (Caldwell-Luc procedure) requires preparation of a mucoperiosteal flap in the buccal molar region and to cut an oval window in the thus exposed bone, without damage to the subjacent maxillary sinus membrane. The procedure is very invasive and subjects the patient to great stress as a result of substantial swelling and discoloration of up to 10 days, and possibly of pain. This surgical procedure is oftentimes referred to as "open" or "classic" sinus lift. This technique is fraught with many risks and complications because of the limitations of healing potential in the maxillary sinus. In spite of these risks many patients undergo this procedure because of the strong desire to replace missing maxillary teeth with dental implants.
An alternative approach to the maxillary sinus from the inferior approach of the alveolar ridge utilizing solid cylindrical osteotomes was described by Dr. Summers (crestal sinus lift). It is a more conservative approach and is less invasive. It was developed to eliminate the risks described above.While this technique is safer, an overzealous use of an osteotome during the placement of the regenerative material can result in the perforation of the subantral membrane with disadvantages discussed above.
Dr. Eder has developed an innovative way - the JEDER System - of carrying out a crestal sinus lift that substantially reduces the risk of perforating the subantral membrane. This minimal- invasive way uses 2 newly developed and successfully patented instruments, the "Druckkammerknochenfräse" DKK and the "Sinusvibrationspumpe" SVP. Following JEDER Syst. the mucous membrane of the mouth is opened from the toothless part of the maxillary crest up to the bone and the bone is scraped by a cylindrical cutter in the shape of a tunnel up to slightly underneath the maxillary sinus membrane.
The aim of the study is to assess the efficacy and safety of the JEDER Syst., which was already demonstrated in 50 treatment attempts. The results of this study will be used for the certification process to enable the declaration of conformity for the market approval.
The main outcome parameter is the perforation rate of the subantral membrane intraoperatively and within 6 weeks after the operation.
Risk benefit assessment:
In the present study there will be no additional examinations undertaken compared to patients which undergo the conventional procedure. The conventional procedure is associated with a risk of membrane perforation and consecutive diseases like infection, swelling and pain. All these inconveniences should be avoided by using the JEDER Syst. If the worst case scenario - the perforation of the subantral membrane - happens, the conventional method will be used. Therefore, the risk-benefit assessment
Study Overview
Status
Study Type
Enrollment (Anticipated)
Phase
- Phase 1
Contacts and Locations
Study Contact
- Name: Andreas Bayerle, MBA
- Email: abayerle@yahoo.com
Study Contact Backup
- Name: Michaela Bayerle-Eder, Prof.,
- Email: michaela.bayerle-eder@meduniwien.ac.at
Study Locations
-
-
Vienna
-
Vienna,, Vienna, Austria, 1130
- Recruiting
- Ordination Dr. Klaus Eder
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- demand for sinus floor elevation (regio 4 to 7)
- loss of teeth (regio 4 to 7)
- needed extraction of teeth (regio 4 to 7)
Exclusion Criteria:
- maxillary bone mass <3mm
- severe chronic illness or immune deficiency
- cortisone therapy
- sinus membrane membrane hight >5mm
- chronic sinusitis
- smoking >20 Zigarettes
- missing dental hygiene
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
perforation rate of the subantral membrane in the sinus maxillaris
Time Frame: intraoperativ and within 6 weeks after the operation
|
intraoperativ and within 6 weeks after the operation
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Michaela M Bayerle-Eder, Prof., MD, MBA, Medical University Vienna, Vienna Austria, Europe
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- DKK-SVP-10 Prot. 1.4
- EK_10_101_0610 (OTHER: Ethikkommission-Vienna-Austria-Europe:)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insufficient Bone Mass in the Maxilla for Dental Implants
-
Carmel Medical CenterTechnion, Israel Institute of TechnologyCompletedInsufficient Bone Volume in Posterior MaxillaIsrael
-
University of MichiganBioHorizons, Inc.CompletedDental Implant Soft Tissue Defects in the Anterior MaxillaUnited States
-
University of Sao PauloCompletedDental Implants | Sinus Floor Augmentation | Platelet-rich Fibrin | Maxillary Sinus | Cone-beam Computed Tomography | Bone Substitutes | Atrophic MaxillaBrazil
-
King Khalid UniversityNot yet recruitingEvaluation of Osseointegration and Stability of Dental Implants in Bone Density Enhanced by Osseodensification Technique
-
RWTH Aachen UniversityInstitut Straumann AGUnknownBone Resorption | Dental Implants | Alveolar Bone Loss | Edentulous Maxilla | Edentulous Patient
-
Arthrex, Inc.RecruitingHyperpronated Foot | Reconstruction Surgeries of the Foot | Fixation of Fractures and Fusion (Bunionectomy Osteotomies) of the Foot/Ankle | Fixation of Small Bone Fragments of the Foot/Ankle | Lisfranc Arthrodesis | Mono or Bi-cortical Osteotomies in the Forefoot | First Metatarsophalangeal Arthrodesis and other conditionsGermany, United States, South Africa